Berenberg Bank reiterated their buy rating on shares of CLS (LON:CLI) in a report released on Wednesday, Digital Look reports. The firm currently has a GBX 275 ($3.59) price target on the stock.
CLI has been the subject of several other research reports. Peel Hunt restated a buy rating on shares of CLS in a research note on Friday, August 9th. Liberum Capital restated a buy rating on shares of CLS in a research note on Wednesday.
LON CLI traded down GBX 0.50 ($0.01) during trading hours on Wednesday, hitting GBX 220 ($2.87). The company had a trading volume of 101,281 shares, compared to its average volume of 117,533. The company has a current ratio of 1.02, a quick ratio of 0.65 and a debt-to-equity ratio of 74.93. CLS has a 1-year low of GBX 195 ($2.55) and a 1-year high of GBX 257 ($3.36). The stock has a market cap of $896.27 million and a P/E ratio of 7.21. The firm has a 50 day moving average of GBX 224.72.
The firm also recently announced a dividend, which will be paid on Friday, September 27th. Stockholders of record on Thursday, August 22nd will be paid a dividend of GBX 2.35 ($0.03) per share. The ex-dividend date is Thursday, August 22nd. This represents a dividend yield of 1.03%. CLS’s dividend payout ratio (DPR) is 0.23%.
In other CLS news, insider Andrew Kirkman bought 50,000 shares of the firm’s stock in a transaction dated Wednesday, July 3rd. The stock was acquired at an average price of GBX 220 ($2.87) per share, for a total transaction of £110,000 ($143,734.48). Insiders have bought 70,133 shares of company stock valued at $15,589,954 in the last quarter.
CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments.
See Also: Depreciation
Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.